Huntington Bancshares Inc (HBAN) stock saw a modest uptick, ending the day at $17.2 which represents a slight increase of $0.30 or 1.78% from the prior close of $16.9. The stock opened at $16.87 and ...

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...

Piper Sandler lowered the firm’s price target on Huntington Bancshares (HBAN) to $17 from $17.50 and keeps an Underweight rating on the shares.

Huntington Bancshares (NASDAQ:HBAN – Free Report) had its target price lifted by Truist Financial from $19.00 to $21.00 in a research note released on Tuesday morning,Benzinga reports.

On Tuesday, DA Davidson adjusted its outlook on Huntington Bancshares (NASDAQ:HBAN), currently trading at $17.01, by reducing the price target to $20.50 from the previous $21.50. Despite the price ...